Submitted by Anonymous (not verified) on 27 November 2025 - 10:45
Human medicines European public assessment report (EPAR): Celdoxome pegylated liposomal, doxorubicin hydrochloride, Date of authorisation: 15/09/2022, Revision: 3, Status: Lapsed
Source: